A phase 1 study of CS 5006 for solid tumors
Latest Information Update: 14 Apr 2026
At a glance
- Drugs CS 5006 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 26 Mar 2026 According to CStone media release, IND submissions planned for 2026.
- 30 Aug 2024 New trial record
- 23 Aug 2024 According to CStone media release, IND submissions expected in 2025.